Gland Pharma COO to retire on superannuation by March 31, 2026

Management Changes View source PDF Explain this filing

GLAND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹1801.00

prior close

₹1800.10

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.9%+0.8% vs market

Pharmaceuticals peers, median of 157sector+0.9%+0.7% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Smallcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.2

15m

+0.1

30m

+3.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+0.9+0.8+0.9+0.7

Next day

+4.7-0.8+5.5+0.4+4.3

+4.7+2.1+2.5+2.4+2.3

+4.4+2.9+1.5+2.9+1.5

+2.7+1.8+0.8+2.2+0.5

+2.1+1.5+0.6+2.1-0.1

+4.6+4.6+0.0+4.3+0.3

15d

+1.2+2.1-0.9+1.2-0.0

-0.1-0.3+0.2-0.6+0.5

-5.6-8.6+3.0-10.4+4.8

-2.2+7.0-9.2+3.2-5.3

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

COO Satnam Singh Loomba will retire due to superannuation effective close of business on March 31, 2026. He joined Gland Pharma on May 1, 2024 as COO and will also cease to be Senior Management Personnel from that date. No replacement has been named in this disclosure.

Likely market impact

Planned superannuation retirement, not a surprise. Investors should watch for the successor announcement. Likely neutral.